Literature DB >> 18394918

Breast cancer and pregnancy: challenges of chemotherapy.

Miriam S Lenhard1, Ingo Bauerfeind, Michael Untch.   

Abstract

BACKGROUND: Breast cancer is the second most frequently occurring malignancy during pregnancy. As evidence-based data on diagnostics and treatment is lacking, current recommendations mostly derive from nonrandomized experiences. We reviewed the current literature with focus on chemotherapy during pregnancy and lactation.
RESULTS: The diagnosis of pregnancy associated breast cancer implies the challenge to balance between a life-saving therapy for the mother's breast cancer and a potentially life-threatening therapy for the fetus. With few limitations, surgery and chemotherapy can be performed during pregnancy, preferably in the second and third trimester, whereas radiotherapy and endocrine or antibody treatment should be postponed until after delivery.
CONCLUSION: Breast cancer during pregnancy and lactation remains a therapeutic and ethical multidisciplinary challenge. Close cooperation between all disciplines is inevitable to find an optimal treatment strategy for the mother and her unborn child.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394918     DOI: 10.1016/j.critrevonc.2008.02.007

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

Review 1.  Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Authors:  Jiri Polivka; Irem Altun; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-02-08       Impact factor: 6.543

2.  Pregnancy-associated breast cancer.

Authors:  Erin A Keyser; Barton C Staat; Merlin B Fausett; Andrea D Shields
Journal:  Rev Obstet Gynecol       Date:  2012

Review 3.  Breast cancer in pregnancy: a literature review.

Authors:  S Deckers; F Amant
Journal:  Facts Views Vis Obgyn       Date:  2009

4.  Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database.

Authors:  Soo Youn Bae; Ku Sang Kim; Jeong-Soo Kim; Sae Byul Lee; Byeong-Woo Park; Seok Won Lee; Hyouk Jin Lee; Hong Kyu Kim; Ji-Young You; Seung Pil Jung
Journal:  J Breast Cancer       Date:  2018-12-10       Impact factor: 3.588

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.